Study discovers compounds that can reverse cell ageing

Image
ANI Washington D.C. [USA]
Last Updated : Aug 07 2018 | 3:50 PM IST

In a breakthrough study, researchers have developed new compounds that could reverse human cell ageing. The study was performed at the University of Exeter.

Professor Lorna Harries said that the goal was to help people stay healthier for longer. She added, "This is about health span and quality of life, rather than merely extending lifespan."

In a laboratory study of endothelial cells - which line the inside of blood vessels - researchers tested compounds designed to target mitochondria (the "power stations" of cells).

In the samples used in for the research, the number of senescent cells (older cells that have deteriorated and stopped dividing) was reduced by up to 50 percent. The Exeter team also identified two splicing factors (a component of cells) that play a key role in when and how endothelial cells become senescent.

The findings raise the possibility of future treatments not only for blood vessels - which become stiffer as they age, raising the risk of problems including heart attacks and strokes - but also for other cells.

"As human bodies age, they accumulate old (senescent) cells that do not function as well as younger cells," said Harries, adding, "This is not just an effect of ageing - it's a reason why we age. The compounds developed at Exeter have the potential to tweak the mechanisms by which this ageing of cells happens."

"We used to think age-related diseases like cancer, dementia and diabetes each had a unique cause, but they actually track back to one or two common mechanisms. This research focuses on one of these mechanisms, and the findings with our compounds have potentially opened up the way for new therapeutic approaches in the future," explied Harries.

"This may well be the basis for a new generation of anti-degenerative drugs," she concluded.

The study appears in the journal Aging.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 07 2018 | 3:50 PM IST

Next Story